文献速递糖尿病

年龄对早期1型糖尿病进展过程中β细胞功能和胰岛素敏感性纵向变化的影响

The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes.
PubMed 文献 · Diabetologia · 2022-12-02

本研究基于糖尿病预防试验-1型(DPT-1)中658例自身抗体阳性参与者的纵向口服葡萄糖耐量试验(OGTT)数据,分析进展至3期1型糖尿病的参与者中年龄对β细胞功能和胰岛素敏感性变化轨迹的影响。结果显示,14岁是1型糖尿病风险的最佳区分年龄,<14岁者进展风险为≥14岁者的两倍;但两组进展者在进展至3期1型糖尿病期间,β细胞葡萄糖敏感性和胰岛素敏感性的年下降速率无显著差异。结论提示,进展至1型糖尿病期间代谢功能下降的轨迹可预测且不受年龄影响。

要点

  • 在DPT-1队列中,1型糖尿病风险的最佳区分年龄为14岁,<14岁参与者进展风险是≥14岁参与者的两倍。
  • <14岁和≥14岁进展者从入组至3期1型糖尿病发病期间,β细胞葡萄糖敏感性和胰岛素敏感性均下降。
  • 两组进展者β细胞葡萄糖敏感性和胰岛素敏感性的年下降速率均无显著差异。

核心结论

  • 进展至3期1型糖尿病期间,<14岁与≥14岁进展者的葡萄糖敏感性和胰岛素敏感性下降速率无显著差异。
  • 数据提示,进展至1型糖尿病期间代谢功能下降的轨迹可预测且不受年龄影响。

研究设计与样本

  • 本研究为糖尿病预防试验-1型(DPT-1)数据的二次分析,对658例自身抗体阳性参与者进行纵向随访,通过OGTT建模测定β细胞功能和胰岛素敏感性。
  • 分析对象为进展至1型糖尿病的参与者(进展者),按年龄<14岁和≥14岁分组,分析β细胞功能和胰岛素敏感性的时间轨迹。

主要发现

  • 在整个DPT-1队列中,1型糖尿病风险的最佳区分年龄为14岁,<14岁参与者进展至1型糖尿病的可能性是≥14岁参与者的两倍。
  • 研究入组时,<14岁进展者和≥14岁进展者的β细胞葡萄糖敏感性受损程度相似。
  • 从研究入组至3期1型糖尿病发病,<14岁和≥14岁进展者的β细胞葡萄糖敏感性和胰岛素敏感性均下降。
  • <14岁进展者与≥14岁进展者的β细胞葡萄糖敏感性年下降速率分别为-13.7(21.2)pmol min-1 m-2 (mmol/l)-1和-11.9(21.5)pmol min-1 m-2 (mmol/l)-1(中位数[IQR]),p=0.52,无显著差异。
  • <14岁进展者与≥14岁进展者的胰岛素敏感性年下降速率分别为-22(37)ml min-1 m-2和-14(40)ml min-1 m-2(中位数[IQR]),p=0.07,无显著差异。

局限性

  • 本文为DPT-1数据的二次分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM/HYPOTHESIS: The risk of progressing from autoantibody positivity to type 1 diabetes is inversely related to age. Separately, whether age influences patterns of C-peptide loss or changes in insulin sensitivity in autoantibody-positive individuals who progress to stage 3 type 1 diabetes is unclear. METHODS: Beta cell function and insulin sensitivity were determined by modelling of OGTTs performed in 658 autoantibody-positive participants followed longitudinally in the Diabetes Prevention Trial-Type 1 (DPT-1). In this secondary analysis of DPT-1 data, time trajectories of beta cell function and insulin sensitivity were analysed in participants who progressed to type 1 diabetes (progressors) to address the impact of age on patterns of metabolic progression to diabetes. RESULTS: Among the entire DPT-1 cohort, the highest discriminant age for type 1 diabetes risk was 14 years, with participants aged <14 years being twice as likely to progress to type 1 diabetes as those aged ≥14 years. At study entry, beta cell glucose sensitivity was impaired to a similar extent in progressors aged <14 years and progressors aged ≥14 years. From study entry to stage 3 type 1 diabetes onset, beta cell glucose sensitivity and insulin sensitivity declined in both progressor groups. However, there were no significant differences in the yearly rate of decline in either glucose sensitivity (-13.7 [21.2] vs -11.9 [21.5] pmol min-1 m-2 [mmol/l]-1, median [IQR], p=0.52) or insulin sensitivity (-22 [37] vs -14 [40] ml min-1 m-2, median [IQR], p=0.07) between progressors aged <14 years and progressors aged ≥14 years. CONCLUSIONS/INTERPRETATION: Our data indicate that during progression to stage 3 type 1 diabetes, rates of change in declining glucose and insulin sensitivity are not significantly different between progressors aged <14 years and progressors aged ≥14 years. These data suggest there is a predictable course of declining metabolic function during the progression to type 1 diabetes that is not influenced by age.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Ferrannini E, Mari A, Monaco GSF, et al. The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes. Diabetologia. 2022. PMID: 36459177. doi:10.1007/s00125-022-05836-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。